Company intelligence / Profile preview

Alzchem

Trostberg, Bavaria, Germany

Ownership: Private
Employees: ~1730
Development stage: Other

Overview

Alzchem is a specialty chemical manufacturer with a strong portfolio of intermediates and raw materials for pharmaceuticals and diagnostics, including high-purity guanidine salts for PCR and APIs such as metformin; no proprietary therapeutics, but its products are used in commercial drugs and diagnostics[2][1].

Therapeutic areas: NeurologyEndocrinologyInfectious DiseasesOther
Modalities: Small moleculeChemical intermediateDietary supplement (creatine)
Industry: Chemicals & Materials

Partnerships

Not explicitly disclosed; standard partnerships with pharmaceutical/diagnostics manufacturers as supplier[2]

Beyond the preview

Go deeper on Alzchem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alzchem.

Explore the full profile